SUBSCRIBE
SUBSCRIBE

Alkermes

NEWS
Biotech Beach
The Day In Review: Dyax Corp. Jumps On Positive Data
April 13, 2007
 · 
1 min read
Biotech Beach
The Day In Review: Novartis Pharmaceuticals Corporation Gets Approval For Hypertensive Drug Tekturna
March 6, 2007
 · 
1 min read
BioForest
The Day In Review: Seattle Genetics, Inc. Sells Cancer Drug To Genentech, Inc.
January 8, 2007
 · 
1 min read
Biotech Bay
Alkermes More Than A Drug Delivery Company
July 17, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Alkermes And Cephalon, Inc. Alcohol Drug Gets Approvable Letter
December 29, 2005
 · 
1 min read
Alkermes’ Alcohol Alchemy
October 19, 2005
 · 
1 min read
Drug Development
The Day In Review: Biotech Gains A Substantial 1+%; A Wealth of Positive News Helps Sector Move Higher
October 19, 2005
 · 
1 min read
Policy
U.S. Study Backs Injectable Drug For Alcoholism
October 19, 2005
 · 
1 min read
Bated Breath For Inhaled Insulin
October 19, 2005
 · 
1 min read
Load More
JOBS
IN THE PRESS
Business
Alkermes to Host Conference Call to Discuss First Quarter 2021 Financial Results
April 21, 2021
 · 
1 min read
Alkermes Presents New Data From Psychiatry Portfolio at Virtual 2021 Congress of the Schizophrenia International Research Society
April 20, 2021
 · 
14 min read
Alkermes Announces Clinical Trial Collaboration and Supply Agreement With MSD to Evaluate Nemvaleukin Alfa in Combination With KEYTRUDA® in Patients With Platinum-Resistant Ovarian Cancer
April 7, 2021
 · 
5 min read
Alkermes to Take Part in Stifel’s 3rd Annual CNS Day
March 25, 2021
 · 
1 min read
Alkermes Investor Day to Focus on Scientific Progress and Value Creation Strategy
March 25, 2021
 · 
5 min read
FDA
Alkermes Announces FDA Orphan Drug Designation for Nemvaleukin Alfa for Treatment of Mucosal Melanoma
March 11, 2021
 · 
5 min read
Alkermes to Hold Virtual Investor Day
March 4, 2021
 · 
1 min read
Alkermes to Take Part in SVB Leerink 10th Annual Global Healthcare Conference
February 18, 2021
 · 
1 min read
Business
Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2020 and Provides Financial Expectations for 2021
February 11, 2021
 · 
22 min read
Alkermes to Host Conference Call to Discuss Fourth Quarter and Year-End 2020 Financial Results
February 4, 2021
 · 
1 min read
Load More